Anthem Biosciences Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs |

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Anthem Biosciences

DeciZen not available for IPO

10 Year X-Ray of Anthem Biosciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 32.5%32.3%29.4%17.2%25.9%25.6%55.4%50.8%31.2%25%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1622093574626266331,1031,2311,0571,418462
Sales YoY Gr.-29.3%70.5%29.6%35.5%1.1%74.4%11.6%-14.2%34.1%-
Adj EPS 0.50.71.20.61.41.64.7766.50
YoY Gr.-56.5%59.7%-51.3%141.1%20.7%189.6%47.5%-14.5%9.9%-
BVPS (₹) 1.52.244.66.17.812.723.830.534.60
Adj Net
Profit
24.839.162.730.573.488.5260397339366NAN
Cash Flow from Ops. 0000196166278333319164-
Debt/CF from Ops. 0000110.40.10.41-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 27.3%17.8%8.7%34.1%
Adj EPS 34.3%37.1%11.5%9.9%
BVPS41.7%41.6%39.6%13.3%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
3638.536.812.82523.546.338.621.919.90
Op. Profit
Mgn %
29.635.430.526.227.428.83745.940.835.7NAN
Net Profit
Mgn %
15.318.717.66.611.71423.632.232.125.8NAN
Debt to
Equity
0.80.90.910.60.40.100.10.1-
Working Cap
Days
1261651481711641721141321982270
Cash Conv.
Cycle
3073738879875467981100

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Anthem Biosciences Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 462 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) 244 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) -
Industry PE 37.8

Quarterly Results

 Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %Mar'25 YoY Gr. Rt. %
Sales (₹ Cr.) 0 N/A0 N/A0 N/A0 N/A
Adj EPS (₹) 0 N/A0 N/A0 N/A0 N/A
Op. Profit Mgn % N/A N/AN/A N/AN/A N/AN/A N/A
Net Profit Mgn % N/A N/AN/A N/AN/A N/AN/A N/A

Management X-Ray of Anthem Biosciences:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Anthem Biosciences

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Anthem Biosciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Sun Pharma Inds. 1,687.6 35.5 (2.2%) Large Cap 48,497 47.7 20.9 34.7 5.5
Dr. Reddys Lab 1,109.2 14 (1.3%) Large Cap 28,011 64.4 19.6 17 2.8
Cipla 1,463.2 46.9 (3.3%) Large Cap 25,774 61.8 15.6 22.9 3.8
Lupin 1,969.1 47.8 (2.5%) Mid Cap 20,011 62.8 9.7 30.6 5.3
Zydus Lifesciences 868.3 23.7 (2.8%) Large Cap 19,547 45.1 19.3 18.7 3.7
Glenmark Pharma 1,377.6 0.7 (0.1%) Mid Cap 11,813 -6.2 -10.2 - 4.4
Torrent Pharma 3,127.5 1 (0%) Large Cap 10,728 55 14.8 56.8 13.2
Aurobindo Pharma 1,082.6 26.1 (2.5%) Mid Cap 10,646 33 17.2 32 3.1
Alkem Laboratories 4,880.4 42.5 (0.9%) Mid Cap 9,748 190.9 18.1 25.4 4.7
Mankind Pharma 2,351.3 37.1 (1.6%) Mid Cap 9,265 47.4 19.6 48.8 6.7
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales161.78209.14356.53462.08626.03632.721,103.241,231.261,056.921,417.54
Operating Expenses 113.92135.13247.74341.10454.28450.80695.50665.80633.88912.53
Manufacturing Costs14.2619.2428.4635.8042.3549.2253.9876.6685.5880.01
Material Costs61.0264.19135.71195.30275.31251.90454.24413.53339.28599.53
Employee Cost 24.4331.0762.5082.29107.23120.15142.19137.51153.24182.65
Other Costs 14.2120.6321.0727.7229.4029.5445.1138.1055.7950.33
Operating Profit 47.8674.01108.78120.98171.75181.92407.74565.45423.04505.01
Operating Profit Margin (%) 29.6%35.4%30.5%26.2%27.4%28.8%37.0%45.9%40.0%35.6%
Other Income 2.474.056.3110.0720.6820.7637.2148.9885.3570.52
Interest 3.703.625.4317.7618.1920.4316.9710.098.719.26
Depreciation 8.9918.4421.5252.8560.5361.5862.4057.7663.7081.49
Exceptional Items 0000000061.800
Profit Before Tax 37.635688.1560.44113.70120.67365.58546.59497.78484.77
Tax 11.7315.3521.9824.6236.6327.9794.27140.60112.11109.99
Profit After Tax 25.9040.6566.1735.8277.0792.70271.31405.99385.67374.78
PAT Margin (%) 16.0%19.4%18.6%7.8%12.3%14.7%24.6%33.0%36.5%26.4%
Adjusted EPS (₹)0.50.81.20.71.41.74.97.16.86.7
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 81.81121.35219.38255.20331.23421.87701.471,355.461,741.621,933.07
Share Capital 8.388.3810.7110.718.388.388.488.78114.10111.82
Reserves 73.43112.97208.67244.48322.85413.49692.991,346.691,627.521,821.26
Minority Interest0000000000
Debt61.91104.20190.73240.67160.46120.87100.0135.49113.93166.59
Long Term Debt43.1977.25155.94171.27137.1095.3019.725.9085.0665.72
Short Term Debt18.7226.9534.7969.4023.3625.5880.2929.5928.88100.87
Trade Payables16.5015.4833.3757.1753.6358.4960.9664.7271.92100.44
Others Liabilities 25.0550.3560.2453.41165.88174.55157.42147.57155.64202.72
Total Liabilities 185.27291.38503.72606.44711.20775.781,019.871,603.242,083.112,402.82

Fixed Assets

Gross Block111.75129.53339.71463.90516.39566.78682.37706.59883.91991.15
Accumulated Depreciation41.3260.8387.37140.21200.73261.21320.96377.58435.02513.45
Net Fixed Assets70.4368.70252.34323.70315.65305.58361.41329.01448.89477.71
CWIP 22.4475.1444.237.2211.5549.8118.59152.68143.41155.91
Investments 20.3424.4726.676.6772.6298.66209.27272.98499.18471.77
Inventories18.8930.0557.8682.7791.56125.4135.0658.23129.42211.31
Trade Receivables31.9849.2173.78121.80117.40105.07254.65326.19274.07489.83
Cash Equivalents 2.573.8911.154.5613.9022.4340.62348.87342.79183.85
Others Assets18.6239.9237.7059.7288.5168.83100.27115.28245.35412.43
Total Assets 185.27291.38503.72606.44711.20775.781,019.871,603.242,083.112,402.82

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 0000196.27165.52277.55333.35318.98164.41
PBT 0000113.70120.67365.58546.59497.78484.77
Adjustment 000077.2976.4677.3947.8526.9137.17
Changes in Working Capital 00005.2913.6-94.43-138.1-90.71-237.54
Tax Paid 00000-45.21-71-123-115-120
Cash Flow From Investing Activity 0000-121.45-109.36-196.09-205.78-377.91-191.76
Capex 0000-52.48-51.13-118.34-89.23-183.53-110.73
Net Investments 0000-66.17-23.80-110.91-1.41-226.2027.41
Others 0000-2.79-34.4433.17-115.1431.82-108.43
Cash Flow From Financing Activity 0000-65.48-47.63-63.27180.6852.85-131.59
Net Proceeds from Shares 0000007.59247.5079.16-19.34
Net Proceeds from Borrowing 0000-48.76-39.59-59.85-13.82-18.368.30
Interest Paid 0000-18.19-20.43-16.97-10.09-0.7271.99
Dividend Paid 0000000000
Others 00001.4712.395.96-42.91-7.22-192.55
Net Cash Flow 00009.348.5318.19308.24-6.07-158.95
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)37.6140.0239.1115.2426.3924.6248.339.4824.9120.4
ROCE (%)32.4932.2929.4217.2425.8725.5655.3650.7831.224.98
Asset Turnover Ratio10.880.90.830.950.851.230.940.570.63
PAT to CFO Conversion(x)00002.551.791.020.820.830.44
Working Capital Days
Receivable Days447163777064608610498
Inventory Days42434556516327143244
Payable Days107916685738148557452

Anthem Biosciences Ltd Stock News

Anthem Biosciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Anthem Biosciences on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Anthem Biosciences stood at ₹0.00.
The latest P/E ratio of Anthem Biosciences as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Anthem Biosciences as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Anthem Biosciences is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Anthem Biosciences is ₹462.1 ( Cr.) .

About Anthem Biosciences Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...